 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, January 1, 2001, 21(1):136-142
Vaccination for Neuroprotection in the Mouse Optic Nerve: Implications for Optic Neuropathies
Jasmin Fisher1, Hanna Levkovitch-Verbin1, Hadas Schori1, Eti Yoles1, Oleg Butovsky1, Joel F. Kaye2, Avraham Ben-Nun2, and Michal Schwartz1 Departments of 1 Neurobiology and 2 Immunology, The Weizmann Institute of Science, Rehovot, Israel
T-cell autoimmunity to myelin basic protein was recently shown to be neuroprotective in injured rat optic nerves. In the present study, using the mouse optic nerve, we examined whether active immunization rather than passive transfer of T-cells can be beneficial in protecting retinal ganglion cells (RGCs) from post-traumatic death. Before severe crush injury of the optic nerve, SJL/J and C3H.SW mice were actively immunized with encephalitogenic or nonencephalitogenic peptides of proteolipid protein (PLP) or myelin oligodendrocyte glycoprotein (MOG), respectively. At different times after the injury, the numbers of surviving RGCs in both strains immunized with the nonencephalitogenic peptides pPLP 190-209 or pMOG 1-22 were significantly higher than in injured controls treated with the non-self-antigen ovalbumin or with a peptide derived from
-amyloid, a non-myelin-associated protein. Immunization with the encephalitogenic myelin peptide pPLP 139-151 was beneficial only when the disease it induced, experimental autoimmune encephalomyelitis, was mild. The results of this study show that survival of RGCs after axonal injury can be enhanced by vaccination with an appropriate self-antigen. Furthermore, the use of nonencephalitogenic myelin peptides for immunization apparently allows neuroprotection without incurring the risk of an autoimmune disease. Application of these findings might lead to a promising new approach for treating optic neuropathies such as glaucoma.
Key words: vaccination; neuroprotection; myelin; T-cells; CNS injury; autoimmunity; optic nerve
Copyright © 2001 Society for Neuroscience 0270-6474/01/211136-07$05.00/0
This article has been cited by other articles:
S. Rossignol, M. Schwab, M. Schwartz, and M. G. Fehlings
Spinal Cord Injury: Time to Move?
J. Neurosci., October 31, 2007; 27(44): 11782 - 11792.
[Abstract] [Full Text] [PDF]
F. H. Grus, S. C. Joachim, K. Bruns, K. J. Lackner, N. Pfeiffer, and M. B. Wax
Serum Autoantibodies to {alpha}-Fodrin Are Present in Glaucoma Patients from Germany and the United States.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 968 - 976.
[Abstract] [Full Text] [PDF]
H. Schori, E. Robenshtok, M. Schwartz, and A. Hourvitz
Post-Intoxication Vaccination for Protection of Neurons against the Toxicity of Nerve Agents
Toxicol. Sci., September 1, 2005; 87(1): 163 - 168.
[Abstract] [Full Text] [PDF]
M. D. Boska, T. B. Lewis, C. J. Destache, E. J. Benner, J. A. Nelson, M. Uberti, R. L. Mosley, and H. E. Gendelman
Quantitative 1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease
J. Neurosci., February 16, 2005; 25(7): 1691 - 1700.
[Abstract] [Full Text] [PDF]
J. Kipnis, H. Avidan, R. R. Caspi, and M. Schwartz
Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia
PNAS, October 5, 2004; 101(suppl_2): 14663 - 14669.
[Abstract] [Full Text] [PDF]
J. Kipnis, M. Cardon, H. Avidan, G. M. Lewitus, S. Mordechay, A. Rolls, Y. Shani, and M. Schwartz
Dopamine, through the Extracellular Signal-Regulated Kinase Pathway, Downregulates CD4+CD25+ Regulatory T-Cell Activity: Implications for Neurodegeneration
J. Neurosci., July 7, 2004; 24(27): 6133 - 6143.
[Abstract] [Full Text] [PDF]
E. J. Benner, R. L. Mosley, C. J. Destache, T. B. Lewis, V. Jackson-Lewis, S. Gorantla, C. Nemachek, S. R. Green, S. Przedborski, and H. E. Gendelman
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
PNAS, June 22, 2004; 101(25): 9435 - 9440.
[Abstract] [Full Text] [PDF]
J. Kipnis, H. Cohen, M. Cardon, Y. Ziv, and M. Schwartz
T cell deficiency leads to cognitive dysfunction: Implications for therapeutic vaccination for schizophrenia and other psychiatric conditions
PNAS, May 25, 2004; 101(21): 8180 - 8185.
[Abstract] [Full Text] [PDF]
T. B. Jones, D. P. Ankeny, Z. Guan, V. McGaughy, L. C. Fisher, D. M. Basso, and P. G. Popovich
Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in Rats
J. Neurosci., April 14, 2004; 24(15): 3752 - 3761.
[Abstract] [Full Text] [PDF]
Z. S. Boyd, A. Kriatchko, J. Yang, N. Agarwal, M. B. Wax, and R. V. Patil
Interleukin-10 Receptor Signaling through STAT-3 Regulates the Apoptosis of Retinal Ganglion Cells in Response to Stress
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5206 - 5211.
[Abstract] [Full Text] [PDF]
E. Hauben, A. Gothilf, A. Cohen, O. Butovsky, U. Nevo, I. Smirnov, E. Yoles, S. Akselrod, and M. Schwartz
Vaccination with Dendritic Cells Pulsed with Peptides of Myelin Basic Protein Promotes Functional Recovery from Spinal Cord Injury
J. Neurosci., September 24, 2003; 23(25): 8808 - 8819.
[Abstract] [Full Text] [PDF]
S. Bakalash, A. Kessler, T. Mizrahi, R. Nussenblatt, and M. Schwartz
Antigenic Specificity of Immunoprotective Therapeutic Vaccination for Glaucoma
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3374 - 3381.
[Abstract] [Full Text] [PDF]
D. N. Angelov, S. Waibel, O. Guntinas-Lichius, M. Lenzen, W. F. Neiss, T. L. Tomov, E. Yoles, J. Kipnis, H. Schori, A. Reuter, et al.
Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis
PNAS, April 15, 2003; 100(8): 4790 - 4795.
[Abstract] [Full Text] [PDF]
M. Schwartz
Neurodegeneration and Neuroprotection in Glaucoma: Development of a Therapeutic Neuroprotective Vaccine: The Friedenwald Lecture
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1407 - 1411.
[Full Text] [PDF]
J. Kipnis, T. Mizrahi, E. Hauben, I. Shaked, E. Shevach, and M. Schwartz
Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system
PNAS, November 26, 2002; 99(24): 15620 - 15625.
[Abstract] [Full Text] [PDF]
T. Mizrahi, E. Hauben, and M. Schwartz
The Tissue-Specific Self-Pathogen Is the Protective Self-Antigen: The Case of Uveitis
J. Immunol., November 15, 2002; 169(10): 5971 - 5977.
[Abstract] [Full Text] [PDF]
K. W. Miller
The nature of sites of general anaesthetic action
Br. J. Anaesth., July 1, 2002; 89(1): 17 - 31.
[Abstract] [Full Text] [PDF]
T. B. Jones, D. M. Basso, A. Sodhi, J. Z. Pan, R. P. Hart, R. C. MacCallum, S. Lee, C. C. Whitacre, and P. G. Popovich
Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy
J. Neurosci., April 1, 2002; 22(7): 2690 - 2700.
[Abstract] [Full Text] [PDF]
E. Hauben, A. Ibarra, T. Mizrahi, R. Barouch, E. Agranov, and M. Schwartz
Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: Comparison with other myelin antigens
PNAS, December 18, 2001; 98(26): 15173 - 15178.
[Abstract] [Full Text] [PDF]
R. Meyer, R. Weissert, R. Diem, M. K. Storch, K. L. de Graaf, B. Kramer, and M. Bahr
Acute Neuronal Apoptosis in a Rat Model of Multiple Sclerosis
J. Neurosci., August 15, 2001; 21(16): 6214 - 6220.
[Abstract] [Full Text] [PDF]
H. Schori, J. Kipnis, E. Yoles, E. WoldeMussie, G. Ruiz, L. A. Wheeler, and M. Schwartz
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma
PNAS, March 1, 2001; (2001) 41609498.
[Abstract] [Full Text]
H. Schori, J. Kipnis, E. Yoles, E. WoldeMussie, G. Ruiz, L. A. Wheeler, and M. Schwartz
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma
PNAS, March 13, 2001; 98(6): 3398 - 3403.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|